the presumptive leader is not defined, which leads to uncertainty and delays when leadership and action is needed,'' the report says..
.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.
.while all of the drugs work on cgrp, they don’t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.